SHANGHAI and CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Jan. 3, 2017 /PRNewswire/ -- WuXi NextCODE, the contract genomics organization enabling precision medicine worldwide, today announced its presentation at the upcoming 35th Annual JP Morgan Healthcare Conference at 9am PT (12 noon ET) on Thursday, January 12th in San Francisco, CA.
WuXi NextCODE COO Hannes Smarason will provide a full corporate overview and update on recent partnerships and milestones in the company's strategy to provide a fully-integrated, global standard platform for using large-scale genomics data to improve healthcare, medicine and wellness for people and populations around the world.
About WuXi NextCODE
WuXi NextCODE is a fully integrated global contract genomics organization. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer comprehensive services that enable population, precision medicine, diagnostics and wellness initiatives and enterprises to use the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a subsidiary of WuXi AppTec. Visit us on the web at wuxinextcode.com.
Edward Farmer, PhD
EVP, Communications and New Ventures
+1 781 775 6206
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wuxi-nextcode-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300384692.html
SOURCE WuXi NextCODE